AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,575,000 | -3.7% | 18,700 | -6.5% | 0.03% | +17.9% |
| Q1 2018 | $1,635,000 | +697.6% | 20,000 | +455.6% | 0.03% | +833.3% |
| Q4 2017 | $205,000 | -98.2% | 3,600 | -97.8% | 0.00% | -97.6% |
| Q3 2017 | $11,120,000 | +364.9% | 166,600 | +258.3% | 0.13% | +252.8% |
| Q2 2017 | $2,392,000 | -42.4% | 46,500 | -34.6% | 0.04% | -42.9% |
| Q1 2017 | $4,152,000 | +90.4% | 71,100 | +72.2% | 0.06% | -12.5% |
| Q3 2016 | $2,181,000 | +426.8% | 41,300 | +304.9% | 0.07% | +260.0% |
| Q1 2016 | $414,000 | – | 10,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |